Nortec Quimica (Via company site)
December 27, 2022 11:03 AM EST
FDA+
Manufacturing

FDA is­sues warn­ing let­ter to South Amer­i­can in­gre­di­ent man­u­fac­tur­er over da­ta prob­lems

Tyler Patchen

News Reporter

A Brazil­ian in­gre­di­ent man­u­fac­tur­er was slapped with an FDA warn­ing let­ter re­lat­ed to al­leged elec­tron­ic da­ta and soft­ware sys­tem prob­lems.

The

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

No­var­tis pays $150M up­front to Schrödinger in new drug deal, ramps up soft­ware use

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times